These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transforming growth factor-beta as a treatment target in renal diseases. Fukuda N; Tahira Y; Matsuda H; Matsumoto K J Nephrol; 2009; 22(6):708-15. PubMed ID: 19967649 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Gressner OA; Gressner AM Liver Int; 2008 Sep; 28(8):1065-79. PubMed ID: 18783549 [TBL] [Abstract][Full Text] [Related]
5. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Leask A Circ Res; 2010 Jun; 106(11):1675-80. PubMed ID: 20538689 [TBL] [Abstract][Full Text] [Related]
6. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta. Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272 [TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435 [TBL] [Abstract][Full Text] [Related]
8. [Connective tissue growth factor (CTGF): a key factor in the onset and progression of kidney damage]. Sánchez-López E; Rodrigues Díez R; Rodríguez Vita J; Rayego Mateos S; Rodrigues Díez RR; Rodríguez García E; Lavoz Barria C; Mezzano S; Egido J; Ortiz A; Ruiz-Ortega M; Selgas R Nefrologia; 2009; 29(5):382-91. PubMed ID: 19820749 [TBL] [Abstract][Full Text] [Related]
9. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ. Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224 [TBL] [Abstract][Full Text] [Related]
10. Effect of transforming growth factor-beta1 on expression of the connective tissue growth factor (CCN2/CTGF) gene in normal human gingival fibroblasts and periodontal ligament cells. Takeuchi H; Kubota S; Murakashi E; Fukada T; Hashimoto S; Takigawa M; Numabe Y J Periodontal Res; 2009 Apr; 44(2):161-9. PubMed ID: 19210343 [TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482 [TBL] [Abstract][Full Text] [Related]
12. Role of connective tissue growth factor in experimental radiation nephropathy in rats. Liu DG; Wang TM Chin Med J (Engl); 2008 Oct; 121(19):1925-31. PubMed ID: 19080126 [TBL] [Abstract][Full Text] [Related]
13. Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis. Mason RM Int J Exp Pathol; 2013 Feb; 94(1):1-16. PubMed ID: 23110747 [TBL] [Abstract][Full Text] [Related]
14. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Abraham D Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153 [TBL] [Abstract][Full Text] [Related]
15. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. Sullivan DE; Ferris M; Pociask D; Brody AR J Immunotoxicol; 2008 Apr; 5(2):145-9. PubMed ID: 18569384 [TBL] [Abstract][Full Text] [Related]
16. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Sonnylal S; Shi-Wen X; Leoni P; Naff K; Van Pelt CS; Nakamura H; Leask A; Abraham D; Bou-Gharios G; de Crombrugghe B Arthritis Rheum; 2010 May; 62(5):1523-32. PubMed ID: 20213804 [TBL] [Abstract][Full Text] [Related]
17. CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis. Yang YL; Lin SH; Chuang LY; Guh JY; Liao TN; Lee TC; Chang WT; Chang FR; Hung MY; Chiang TA; Hung CY J Cell Biochem; 2007 Jun; 101(3):735-44. PubMed ID: 17226761 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis. Danilewicz M; Wagrowska-Danilewicz M Pol J Pathol; 2006; 57(4):193-8. PubMed ID: 17285762 [TBL] [Abstract][Full Text] [Related]